Skip to main content
SpringerLink
Log in

Pure red cell aplasia complicating the course of long-standing mantle cell lymphoma

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Pure red cell aplasia (PRCA) is a rare cause of severe hypoplastic anemia characterized by profound depletion of erythroid precursors. Although PRCA may be associated with lymphoproliferative diseases, it has never been described in mantle cell lymphoma (MCL). We report what to our knowledge is the first case of a patient with indolent, non-nodal MCL complicated by PRCA. The patient presented with severe hypoproliferative anemia in the setting of a long-standing diagnosis of B-cell chronic lymphocytic leukemia. Bone marrow studies revealed the complete absence of erythroid progenitors. Cyclin D1 positivity on immunohistochemistry, confirmed by a positive FISH for t(11;14) (q13;q32), established the final diagnosis of MCL in conjunction with PRCA. Rituximab monotherapy led to rapid remission of splenomegaly and the leukemic picture, but the patient achieved transfusion independency only with subsequent administration of cyclosporine-A, and remained so during the subsequent 15 months despite the gradual disease recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Charles RJ, Sabo KM, Kidd PG, Abkowitz JL. The pathophysiology of pure red cell aplasia: implications for therapy. Blood. 1996;87:4831–8.

    CAS  PubMed  Google Scholar 

  2. Maciejewski JP, Tiu RV. Acquired disorders of red cell and white cell production. In: Hoffman R, Benz EJ, Silberstein EL, Heslop HE, Weitz JR, Anastasi J, editors. Hematology basic principles and practice. 6th ed. Philadelphia: Elsevier Saunders; 2013. p. 383–9.

    Google Scholar 

  3. Vlachaki Ε, Tselios Κ, Charalambidou S, Ioannidou E, Klonizakis I. Pure red cell aplasia complicating B cell small lymphocytic lymphoma: a case report. Int J Hematol. 2008;88:341–2.

    Article  PubMed  Google Scholar 

  4. Anastasiadis Α, Margaritis D, Kotsianidis I, Spanoudakis E, Christoforidou A, Kostopoulos I, et al. Pure red cell aplasia as first manifestation of splenic marginal zone lymphoma-successful treatment with rituximab: a case report. Cases J. 2009;2:6913.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Vlachaki E, Diamantidis MD, Klonizakis P, Haralambidou-Vranitsa S, Ioannidou-Papagiannaki E, Klonizakis I. Pure red cell aplasia and lymphoproliferative disorders: an infrequent association. Sci World J. 2012;2012:475313.

    Article  Google Scholar 

  6. Hauswirth AW, Skrabs C, Schutzinger C, Gaiger A, Lechner K, Jager U. Autoimmune hemolytic anemias, Evans’ syndromes, and pure red cell aplasia in non-Hodgkin lymphomas. Leuk Lymphoma. 2007;48:1139–49.

    Article  PubMed  Google Scholar 

  7. Hirokawa M, Sawada K, Fujishima N, Kawano F, Kimura A, Watanabe T, et al. Acquired pure red cell aplasia associated with malignant lymphomas: a nationwide cohort study in Japan for the PRCA Collaborative Study Group. Am J Hematol. 2009;84:144–8.

    Article  PubMed  Google Scholar 

  8. Swerdlow SH, Campo E, Seto M, Müller-Hermelink HK. Mantle cell lymphoma. In: Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Τhiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th edn. International Agency for Research on Cancer (IARC), 2008.

  9. Korkolopoulou P, Vassilakopoulos TP. Topoisomerase IIalpha as a prognostic factor in mantle cell lymphoma. Leukemia. 2004;18:1347–9.

    Article  CAS  PubMed  Google Scholar 

  10. Von Hohenstaufen KA, Conconi A, de Campos CP, Franceschetti S, Bertoni F, Margiotta Casaluci G, et al. Prognostic impact of monocyte count at presentation in mantle cell lymphoma. Br J Haematol. 2013;162:465–73.

    Article  Google Scholar 

  11. Romaguera JE, Fayad L, Rodriguez MA, Broglio KR, Hagemeister FB, Pro B, et al. High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine. J Clin Oncol. 2005;23:7013–23.

    Article  CAS  PubMed  Google Scholar 

  12. Dreyling M, Lenz G, Hoster E, Van Hoof A, Gisselbrecht C, Schmits R, et al. Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network. Blood. 2005;105:2677–84.

    Article  CAS  PubMed  Google Scholar 

  13. Sachanas S, Pangalis GA, Vassilakopoulos TP, Korkolopoulou P, Kontopidou FN, Athanasoulia M, et al. Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimen. Leuk Lymphoma. 2011;52:387–93.

    Article  PubMed  Google Scholar 

  14. Dreyling M, Kluin-Nelemans HC, Beà S, Klapper W, Vogt N, Delfau-Larue MH, et al. Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network. Leuk Lymphoma. 2013;54:699–707.

    Article  CAS  PubMed  Google Scholar 

  15. Kluin-Nelemans HC, Hoster E, Hermine O, Walewski J, Trneny M, Geisler CH, et al. Treatment of older patients with mantle-cell lymphoma. N Engl J Med. 2012;367:520–31.

    Article  CAS  PubMed  Google Scholar 

  16. Angelopoulou MK, Siakantaris MP, Vassilakopoulos TP, Kontopidou FN, Rassidakis GZ, Dimopoulou MN, et al. The splenic form of mantle cell lymphoma. Eur J Haematol. 2002;68:12–21.

    Article  PubMed  Google Scholar 

  17. Fernàndez V, Salamero O, Espinet B, Solé F, Royo C, Navarro A, et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res. 2010;70:1408–18.

    Article  PubMed  Google Scholar 

  18. Orchard J, Garand R, Davis Z, Babbage G, Sahota S, Matutes E, et al. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, non nodal disease. Blood. 2003;101:4975–81.

    Article  CAS  PubMed  Google Scholar 

  19. Ondrejka SL, Lai R, Kumar N, Smith SD, Hsi ED. Indolent mantle cell leukemia: clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, κ light chain restriction, and good prognosis. Haematologica. 2011;96:1221–7.

    Article  Google Scholar 

  20. Martin P, Chadburn A, Christos P, Weil K, Furman RR, Ruan J, et al. Outcome of deferred initial therapy in mantle-cell lymphoma. J Clin Oncol. 2009;27:1209–13.

    Article  PubMed  Google Scholar 

  21. Li G, Li ZQ, Yang QY, Yang JD. Acquired pure red cell aplasia due to treatment with clopidogrel: first case report. J Thromb Thrombolysis. 2013 (Epub ahead of print).

  22. Alter R, Joshi S, Verdirame JD, Weisenburger DD. Pure red cell aplasia associated with B cell lymphoma: demonstration of bone marrow colony inhibition by serum immunoglobulin. Leuk Res. 1990;14:279–86.

    Article  CAS  PubMed  Google Scholar 

  23. Handgretinger R, Geiselhart A, Moris A, Grau R, Teuffel O, Bethge W, et al. Pure red cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors. N Engl J Med. 1999;340:278–84.

    Article  CAS  PubMed  Google Scholar 

  24. Dessypris EN, Lipton JM. Red cell aplasia. Ιn: Greer JP, Foerster J, Lukens JN, Rogers GM, Paraskevas MD, Glader B, editors. Wintrobe’s Clinical Hematology, 12th edn. Philadelphia: Lippincott, Williams & Wilkins, 2009:1196–11.

  25. Higuchi T, Mori H, Niikura H, Omine M. Hypocomplementemia and hematological abnormalities in immunoblastic lymphadenopathy and immunoblastic lymphadenopathy-like T cell lymphoma. Acta Haematol. 1996;96:68–72.

    Article  CAS  PubMed  Google Scholar 

  26. Loughran TP. Clonal diseases of large granular lymphocytes. Blood. 1993;82:1–14.

    PubMed  Google Scholar 

  27. Dungarwalla M, Marsh JCW, Tooze JA, Lucas G, Ouwehand W, Petengell R, et al. Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology. Ann Hematol. 2007;86:191–7.

    Article  CAS  PubMed  Google Scholar 

  28. Michishita Y, Hirokawa M, Fujishima N, Abe Y, Fujishima M, Guo Y-M, et al. CDR3-independent expansion of Vδ1 Τ lymphocytes in acquired chronic pure red cell aplasia. Immunol Let. 2013;150:23–9.

    Article  CAS  Google Scholar 

  29. Ghazal H. Succesful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia. Blood. 2002;99:1092–4.

    Article  CAS  PubMed  Google Scholar 

  30. D’Arena G, Guariglia R, La Rocca F, Trino S, Condelli V, DeMartino L, et al. Autoimmune cytopenias in chronic lymphocytic leukemia. Clin Dev Immunol. 2013;2013:730131.

    PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have not conflict of interest.

Author information

Authors and Affiliations

  1. Department of Haematology, School of Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, 11527, Athens, Greece

    Alexander Kanellopoulos, Katrina Koutsi, George Georgiou, Themis Ntalagiorgos, Kyriaki Petevi, George Boutsikas, Loula Papageorgiou, Gabriela Gainaru, Pagona Flevari, Maria K. Angelopoulou, John Meletis & Theodoros P. Vassilakopoulos

Authors
  1. Alexander Kanellopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katrina Koutsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. George Georgiou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Themis Ntalagiorgos
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kyriaki Petevi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. George Boutsikas
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Loula Papageorgiou
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Gabriela Gainaru
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Pagona Flevari
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Maria K. Angelopoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. John Meletis
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Theodoros P. Vassilakopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Theodoros P. Vassilakopoulos.

About this article

Cite this article

Kanellopoulos, A., Koutsi, K., Georgiou, G. et al. Pure red cell aplasia complicating the course of long-standing mantle cell lymphoma. Int J Hematol 99, 777–781 (2014). https://doi.org/10.1007/s12185-014-1563-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-014-1563-5

Keywords

Search

Navigation